Multi-Organ Autonomic Electrophysiology in Parkinson Disease
Principal Investigator: Samay Jain
Abstract: DESCRIPTION (provided by applicant): Samay Jain M.D., M.S. is a junior faculty member in the University of Pittsburgh, Department of Neurology Movement Disorders Division since 2006. In 2007, Dr. Jain began participating in the Multidisciplinary Clinical Research Scholars Program with funding through the KL2/K12 mechanism for a proposal entitled, "Improving diagnosis and treatment of Parkinson disease with assessments of non-motor features by clinical and physiologic measures." As part of this program, he has completed a Masters of Science in Clinical Research and generated preliminary data for this K23 application. Although this has provided formal training on general clinical research methodology, what the candidate lacks are specific skills necessary to conduct his specialized area of research: electrophysiological measures of autonomic function in Parkinson disease (PD). The six objectives of this five year career development proposal are to: (1) Refine research skills in movement disorders and autonomic function;(2) Acquire skills to gather, analyze and interpret electrophysiological data;(3) Apply successful strategies of geriatric clinical research to recruit and retain an elderly cohort;(4) Develop expertise in pharmacology as it relates to autonomic function and PD;(5) Apply biostatistics for hypothesis testing of longitudinal and complex physiologic data;and (6) Integrate research skills into efficient scientific writing. The primary mentor overseeing all activities is Dr. J. Timothy Greenamyre. The career development plan utilizes resources available with mentors, consultants and coursework in the areas of neurology, physiology, geriatrics, pharmacology and biostatistics. All data and analyses presented here were done in the facilities of mentors and consultants with close supervision and discussion. These resources, which continue to be available for this proposal, include a new, fully equipped physiological laboratory dedicated solely to the candidate's research where training and testing occur;two additional physiological laboratories of mentors available for testing and training, the Pittsburgh Claude D. Pepper Older Americans Independence Center with resources for recruitment and retention of geriatric participants;the Pittsburgh Institute for Neurodegenerative diseases;and the Comprehensive Movement Disorders Center. In addition, education and expertise at the NIH Clinical Center in Bethesda, MD will be available through co-mentor Dr. David S. Goldstein. The immediate goal of the career development plan is to for the PI to achieve independence in conducting autonomic electrophysiological research in PD. The long term goal is to become a leader in clinical research utilizing autonomic measures to develop treatments for non-motor features of PD and monitor PD progression in interventional trials with non-invasive electrophysiological techniques. PD is the second most common neurodegenerative disease affecting over one-million Americans with annual cost of $23 billion. Non-motor features, including autonomic symptoms, occur in 90% of PD patients and account for greater influence on quality of life and healthcare costs than impairment in motor function. Our goal is to develop non-invasive measures that will allow understanding of autonomic physiology in PD. This will reduce the burden of PD by informing diagnostic and treatment strategies. We seek to integrate autonomic physiology, motor features and anti-parkinsonian medications in a model of PD that can be applied to interventional PD trials. This challenges current approaches of PD which rely solely on motor impairment as a measure of disease progression. We apply a novel protocol translating techniques from psychophysiology to non-invasively measure autonomic function in PD in the pupillary, cardiovascular (CV) and gastrointestinal (GI) systems. Our specific aims are to: (1) relate autonomic physiology in the pupillary, GI and CV systems to PD motor severity;(2) identify mechanisms by which dopaminergic medication influence autonomic physiology in PD;and (3) evaluate the extent to which autonomic dysfunction in the pupillary, CV and GI systems in PD is related to progression of Parkinsonism. To accomplish this, we will compare autonomic measures of 60 individuals PD and 60 age and sex-matched controls, 40 PD participants on and off dopaminergic medication, and follow 60 PD and 40 controls every 6 months for 24 months. As PD severity increases we predict a defined sequence of accumulation in autonomic dysfunction across the GI, CV and pupillary systems upon which anti-parkinsonian medications mediate effects via specific sympathetic and parasympathetic pathways. We also expect the rate of change of autonomic function in PD to correlate with the rate of change in severity of Parkinsonian motor signs. Upon completion of this proposal, the candidate will have applied for R01 funding establishing a foundation to become a leader in clinical research with a sustainable plan to apply autonomic electrophysiology to the diagnosis and treatment of PD as well as understanding mechanisms which underlie PD.
Funding Period: 2011-07-01 - 2016-06-30
more information: NIH RePORT
- Multi-organ autonomic dysfunction in Parkinson diseaseSamay Jain
Clinical Director, Movement Disorders Division, Department of Neurology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213 3232, USA
Parkinsonism Relat Disord 17:77-83. 2011..End-organ physiologic markers may be used to inform a model of PD pathophysiology and non-motor progression...
- Autonomic insufficiency in pupillary and cardiovascular systems in Parkinson's diseaseSamay Jain
University of Pittsburgh School of Medicine, PA, USA
Parkinsonism Relat Disord 17:119-22. 2011..In Parkinson's disease (PD), neurodegenerative changes have been observed in autonomic pathways involving multiple organ systems. We explore pupillary and cardiac autonomic measures as physiological manifestations of PD neurodegeneration...
- Pupillary unrest correlates with arousal symptoms and motor signs in Parkinson diseaseSamay Jain
Movement Disorders Division, Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15213 3232, USA
Mov Disord 26:1344-7. 2011..Arousal symptoms (e.g., sleepiness) are common in Parkinson's disease, and pupillary unrest (spontaneous changes in pupil diameter) is positively associated with sleepiness. We explored pupillary unrest in Parkinson's disease...
- Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesisSamay Jain
Department of Neurology, University of Pittsburgh Medical Center, 3471 Fifth Ave, Suite 811, Kaufmann Medical Building, Pittsburgh, PA 15213 3232, USA
Neurobiol Dis 46:572-80. 2012..This review updates the field of autonomic cardiovascular abnormalities in PD and related disorders, with emphasis on relationships among striatal dopamine depletion, sympathetic noradrenergic denervation, and alpha-synucleinopathy...
- Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health StudyThanh G N Ton
Department of Neurology, School of Medicine, University of Washington, Box 359775, Harborview Medical Center, 325 Ninth Ave, Seattle, WA 98125, USA
Parkinsonism Relat Disord 18:274-8. 2012..We assessed associations of baseline levels of inflammatory markers with prevalent PD at baseline (1989) and incident PD identified over 13 years of follow-up of the Cardiovascular Health Study...
- Olfactory dysfunction and parasympathetic dysautonomia in Parkinson's diseasePeter Kang
University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Clin Auton Res 22:161-6. 2012..Olfactory impairment occurs early in Parkinson’s disease (PD), as may dysautonomia. We investigated the relationship between olfaction and dysautonomia as well as other non-motor manifestations of PD...
- Cardiovascular physiology in premotor Parkinson's disease: a neuroepidemiologic studySamay Jain
University of Pittsburgh School of Medicine, Department of Neurology, Pittsburgh, PA 15213, USA
Mov Disord 27:988-95. 2012..Replication is needed in a population with more thorough ascertainment of PD onset...
- Massachusetts Alzheimer's Disease Research CenterBradley T Hyman; Fiscal Year: 2013..Going forward, the MADRC will continue to expand its clinical and neuropathological resources, its innovative training and scientific programs directed toward AD research. ..
- Spatial and Temporal Scales of Motor Sequence LearningSCOTT THOMAS GRAFTON; Fiscal Year: 2013..The collaborative effort can be expected to significantly advance our knowledge about mechanisms that support motor cortex plasticity. ..
- Center for Novel Therapeutics for HIV-Associated Cognitive DisordersJustin C McArthur; Fiscal Year: 2013..5. To identify and validate surrogate biomarkers based on proteomics and lipomics. ..
- Indiana Alzheimer Disease CenterAndrew J Saykin; Fiscal Year: 2013..abstract_text> ..
- DRUG DEPENDENCE CLINICAL RESEARCH PROGRAMReese T Jones; Fiscal Year: 2013..abstract_text> ..
- Alzheimer's Disease Research CenterOscar L Lopez; Fiscal Year: 2013..Alzheimer's centers such as the one in Pittsburgh play a critical role in the nation's struggle to: 1) care for those currently afflicted;2) improve diagnosis and treatment;and 3) find a means of prevention. ..
- MOLECULAR GENETICS OF COAGULATION DISORDERSDavid Ginsburg; Fiscal Year: 2013..This Project will identify key genes in this system that should provide valuable new diagnostic tools as well as suggest novel approaches to treatment. ..
- Emory Alzheimer's Disease CenterAllan I Levey; Fiscal Year: 2013..abstract_text> ..
- Neuroimaging for Early Diagnosis of Manganese Toxicity in Humans and RodentsUlrike Dydak; Fiscal Year: 2013....
- Integrating Structive Activity, Biokinetics and Response for ENP Risk AssessmentBrian D Thrall; Fiscal Year: 2013....
- Washington National Primate Research CenterDavid M Anderson; Fiscal Year: 2013..All lentivirus-infected primates are housed in ABSL2/3 containment facilities with appropriate biosafety procedures. The University of Washington, including the WaNPRC, is fully accredited by AAALAC International. ..
- Regulatory Mechanisms In Intestinal MotilityKenton M Sanders; Fiscal Year: 2013..The investigative team is highly synergistic and collaborative, and the PPG has a long track-record of productivity and novel discovery ..
- Injury and Recovery in Developing BrainFlora M Vaccarino; Fiscal Year: 2013..The long-term goal of these studies is to identify new means of therapeutic intervention to decrease the developmental disability and neurobehavioral sequelae of preterm birth. ..
- Comprehensive NeuroAIDS Core CenterKamel Khalili; Fiscal Year: 2013..abstract_text> ..